Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 19 - Number 1

Commentary   Open Access

Targeted Nanotechnology from Bench to Bedside

, 19(1): 3 - 4

Konstantinos Sapalidis, Christoforos Kosmidis, Stela Laskou, Athanasios Katsaounis, Stylianos Mantalobas, Ioannis Passos, Nikolaos Michalopoulos, Aikaterini Amaniti, Chrysa Sardeli and Paul Zarogoulidis*

DOI: 10.2174/156800961901181204130142

Review Article

Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases

, 19(1): 5 - 16

Oliesia Gonzalez Quiñones and Maria Bernadete Riemma Pierre*

DOI: 10.2174/1568009618666180430125201

Review Article

Review Article

Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?

, 19(1): 26 - 40

A.P. Alves, A.C. Mamede, M.G. Alves, P.F. Oliveira, S.M. Rocha, M.F. Botelho and C.J. Maia*

DOI: 10.2174/1568009618666180430144441

Systemic Review Article

Crizotinib Versus Chemotherapy on ALK-positive NSCLC: A Systematic Review of Efficacy and Safety

, 19(1): 41 - 49

Mingxia Wang, Guanqi Wang, Haiyan Ma and Baoen Shan*

DOI: 10.2174/1568009617666170623115846

Research Article

The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy

, 19(1): 50 - 64

Yiting Yin, Xin Qi, Yuan Qiao, Huaxiang Liu, Zihan Yan, Hao Li and Zhen Liu*

DOI: 10.2174/1568009618666181003170027

Research Article

Specific Targeting of HER2-Positive Head and Neck Squamous Cell Carcinoma Line HN5 by Idarubicin-ZHER2 Affibody Conjugate

, 19(1): 65 - 73

Marzieh Ghanemi, Aminollah Pourshohod, Mohammad Ali Ghaffari, Alireza kheirollah, Mansour Amin, Majid Zeinali* and Mostafa Jamalan*

DOI: 10.2174/1568009617666170427105417

Research Article   Open Access


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog